Rodrigo Escalona, MD, is affiliated with the New Mexico VA Health Care System and the University of New Mexico School of Medicine, Department of Psychiatry and Behavioral Sciences. His publications between 2004 and 2023 focus on clinical topics including addiction, schizophrenia and schizoaffective disorders, and somatoform disorders. His work includes studies on the use of pramipexole as an adjunct treatment in opioid use disorder and case reports on psychosis related to substance use.
Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.
